Incidence:  In the United States, at least 500,000 people are believed to suffer from Parkinson's disease, and about 50,000 new cases are reported annually. These figures are expected to increase as the average age of the population increases. The disorder appears to be slightly more common in men than women. The average age of onset is about 60.

http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease_backgrounder.htm

 

Medical Cannabis Indication:  Parkinson's Disease

          Improves:  Dystonia (involuntary muscle contractions),

                            Dyskinesia (involuntary muscle movements),

                            Akinesia (impairment of voluntary movements),

                            Neuropathic Pain, Quality of sleep, Muscle Relaxation

Recommended cannabinoid ratios:  

                     equal ratio THC: CBD (e.g. 1:1) 

                     high THC : low CBD (e.g. 20:1)

Dosing:  

Go slow and start dosing low and titrate until desired results are achieved.

 (Combination of  the above products may be required).  THC doses greater than 10mg/dose not recommended

Other:  

Neuroprotective properties may slow progression of disease.

Cannabinoid replacement therapy may reduce symptoms and prolong survival. 

(Please note that cannabinoid therapy is patient specific and may require dose/concentration adjustment. Please consult with your provider for appropriate therapy options.)

 

 

References: 

Journal Articles:

Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study.

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial